


Cardiorenal QSP Revenue
Biotechnology Research • • 1-10 Employees
Cardiorenal QSP revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Cardiorenal QSP
Melissa Hallow
Founder and Principal Consultant
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About Cardiorenal QSP
Cardiorenal QSP helps pharmaceutical companies navigate complex cardiorenal drug development challenges through mechanistic modeling and quantitative systems pharmacology. Founded by Dr. K. Melissa Hallow, we specialize in applying peer-reviewed models of integrated kidney-cardiovascular function to decode unexpected biomarker findings, optimize combination therapies, and design more informative clinical trials. With 16+ years of expertise in cardiorenal mechanistic modeling and a proven track record in drug development, we serve companies developing treatments for heart failure, chronic kidney disease, hypertension, and related conditions. By connecting molecular mechanisms to physiological responses to clinical outcomes, Cardiorenal QSP enables confident, science-based decision making along the way to new safe and effective therapies for cardiorenal diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Cardiorenal QSP has never raised funding before.
Frequently asked questions
4.8
40,000 users



